JP2011137030A - Pest controlling composition, and method for controlling pest - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a pest controlling composition having excellent controlling efficacy on pests. <P>SOLUTION: The pest controlling composition including clothianidin, and at least one pesticidal compound selected from (A) [the group consisting of mancozeb, mefenoxam, and metalaxyl] has the excellent controlling efficacy on the pests. The pest controlling composition further including at least one pesticidal compound selected from (B) [the group consisting of pyraclostrobin, azoxystrobin, and trifloxystrobin, the group consisting of metconazole, prothioconazole, triticonazole, tebuconazole, difenoconazole, and ipconazole, and the group consisting of thiophanate-methyl, fludioxonil, tolclofos-methyl, thiuram, captan, carboxin, boscalid, and thiabendazole] has the excellent controlling efficacy on the pests. <P>COPYRIGHT: (C)2011,JPO&INPIT

Description

  The present invention relates to a pest control composition and a pest control method.

  Conventionally, many compounds are known as an active ingredient of a pest control composition (for example, refer to Patent Documents 1 and 2 and Non-Patent Document 1).

International Publication No. 95/27693 Pamphlet International Publication No. 02/10101 Pamphlet

The Pesticide Manual-15th edition (BCPC publication) ISBN 19013996188

  This invention makes it a subject to provide the composition for pest control which has the outstanding control effect with respect to a pest.

［３］ クロチアニジンと、群（Ａ）より選ばれる１種以上の殺菌化合物と、群（Ｃ）から選ばれる１種以上の殺菌化合物とを含有する有害生物防除組成物。
群（Ａ）：マンコゼブ、メフェノキサム及びメタラキシルからなる群。
群（Ｃ）：メトコナゾール、プロチオコナゾール、トリチコナゾール、テブコナゾール、ジフェノコナゾール及びイプコナゾールからなる群。
［４］ クロチアニジンと、群（Ａ）より選ばれる１種以上の殺菌化合物と、群（Ｄ）から選ばれる１種以上の殺菌化合物とを含有する有害生物防除組成物。
群（Ａ）：マンコゼブ、メフェノキサム及びメタラキシルからなる群。
群（Ｄ）：チオファメートメチル、フルジオキソニル、トルクロホスメチル、チウラム、キャプタン、カルボキシン、ボスカリド及びチアベンダゾールからなる群。
［５］ クロチアニジン１０００重量部に対して、群（Ａ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部の含有割合である［１］〜［４］いずれか一項記載の有害生物防除組成物。
［６］ クロチアニジン１０００重量部に対して、群（Ａ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部、かつ、群（Ｂ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部の含有割合である［２］記載の有害生物防除組成物。
［７］ クロチアニジン１０００重量部に対して、群（Ａ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部、かつ、群（Ｃ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部の含有割合である［３］記載の有害生物防除組成物。
［８］ クロチアニジン１０００重量部に対して、群（Ａ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部、かつ、群（Ｄ）から選ばれる１種以上の殺菌化合物が合計で、２〜１０００００００重量部の含有割合である［４］記載の有害生物防除組成物。
［９］ ［１］〜［８］いずれか一項記載の有害生物防除組成物の有効量を、有害生物又は有害生物の生息場所に施用する工程を有してなる有害生物の防除方法。
［１０］ ［１］〜［８］いずれか一項記載の有害生物防除組成物の有効量を、植物種子に施用する工程を有してなる有害生物の防除方法。
［１１］ 植物種子が、コムギ、ジャガイモ、トウモロコシ、ワタ、ダイズ、テンサイ、ナタネ又はイネの種子である［１０］記載の有害生物の防除方法。 As a result of studying to find a composition for controlling pests having an excellent control effect against pests, the present inventors have found that a composition containing clothianidin and one or more fungicidal compounds selected from the following group (A): Has been found to have an excellent control effect against pests, leading to the present invention.
That is, the present invention includes the following [1] to [11].
[1] A pest control composition comprising clothianidin and one or more fungicidal compounds selected from the group (A).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
[2] A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (B).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (B): A group consisting of a compound represented by the formula (1), pyraclostrobin, azoxystrobin and trifloxystrobin.

[3] A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (C).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (C): A group consisting of metconazole, prothioconazole, triticonazole, tebuconazole, difenoconazole and ipconazole.
[4] A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (D).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (D): A group consisting of thiofamate methyl, fludioxonil, tolcrofosmethyl, thiuram, captan, carboxin, boscalid and thiabendazole.
[5] Any one of [1] to [4], wherein one or more bactericidal compounds selected from the group (A) are a total content of 2 to 10000000 parts by weight with respect to 1000 parts by weight of clothianidin. Pest control composition.
[6] With respect to 1000 parts by weight of clothianidin, one or more bactericidal compounds selected from the group (A) total 2 to 10000000 parts by weight and one or more bactericidal compounds selected from the group (B). The pest control composition according to [2], wherein the content is 2 to 10000000 parts by weight in total.
[7] With respect to 1000 parts by weight of clothianidin, the total of one or more bactericidal compounds selected from group (A) is 2 to 10000000 parts by weight and one or more bactericidal compounds selected from group (C). The pest control composition according to [3], which is a content ratio of 2 to 10000000 parts by weight in total.
[8] With respect to 1000 parts by weight of clothianidin, the total of one or more bactericidal compounds selected from group (A) is 2 to 10000000 parts by weight and one or more bactericidal compounds selected from group (D). The pest control composition according to [4], wherein the content is 2 to 10000000 parts by weight in total.
[9] A method for controlling pests, comprising a step of applying an effective amount of the pest control composition according to any one of [1] to [8] to a pest or a habitat of the pest.
[10] A method for controlling pests, comprising a step of applying an effective amount of the pest control composition according to any one of [1] to [8] to plant seeds.
[11] The pest control method according to [10], wherein the plant seeds are wheat, potato, corn, cotton, soybean, sugar beet, rapeseed or rice seeds.

  According to the present invention, pests can be controlled.

The pest control composition of the present invention (hereinafter referred to as the present composition) may be referred to as clothianidin and one or more bactericidal compounds selected from the group (A) (hereinafter referred to as the present bactericidal compound (A)). Is).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.

  Clothianidin, mancozeb, metalxyl-M and metalaxyl used in the present invention are all known compounds, such as “THE PESTICIDE MANUAL-15th EDITION (published by BCPC) ISBN 19913618. ”, Pages 229, 702, 739, and 737. These compounds can be obtained from commercially available preparations or produced by known methods.

  The content ratio of clothianidin and one or more fungicidal compounds selected from group (A) in the composition of the present invention is not particularly limited, but from 1000 parts by weight of clothianidin from group (A). The total of one or more selected bactericidal compounds is usually 2 to 10000000 parts by weight, preferably 5 to 50000 parts by weight.

  The composition of the present invention may be a mixture of clothianidin and one or more bactericidal compounds selected from the group (A). Usually, these compounds are mixed with an inert carrier, and if necessary, Surfactants and other formulation adjuvants are added and formulated into oils, emulsions, flowables, wettable powders, granular wettable powders, powders, granules and the like. Further, the composition of the present invention can be used as a pest control agent as it is or by adding other inactive components.

群（Ｃ）：メトコナゾール、プロチオコナゾール、トリチコナゾール、テブコナゾール、ジフェノコナゾール及びイプコナゾールからなる群。
群（Ｄ）：チオファメートメチル、フルジオキソニル、トルクロホスメチル、チウラム、キャプタン、カルボキシン、ボスカリド及びチアベンダゾールからなる群。 In addition to clothianidin and one or more fungicidal compounds selected from the group (A), the composition of the present invention may optionally further contain other insecticidal compounds and fungicidal compounds. Examples of such bactericidal compounds include one or more bactericidal compounds selected from the following group (B), one or more bactericidal compounds selected from group (C), and one or more sterilized compounds selected from group (D). Compounds.
Group (B): A group consisting of a compound represented by the formula (1), pyraclostrobin, azoxystrobin and trifloxystrobin.

Group (C): A group consisting of metconazole, prothioconazole, triticonazole, tebuconazole, difenoconazole and ipconazole.
Group (D): A group consisting of thiofamate methyl, fludioxonil, tolcrofosmethyl, thiuram, captan, carboxin, boscalid and thiabendazole.

  The compound represented by the formula (1) (hereinafter sometimes referred to as the present compound (1)) is, for example, a compound described in WO95 / 27693 pamphlet and WO02 / 10101 pamphlet. For example, it can be synthesized by the method described in the pamphlet.

で示される。）及びＳ体（式（１ｂ）

で示される）の両エナンチオマーが存在するが、本発明では任意のエナンチオマー比であるものを本化合物（１）に用いることができる。 In this compound (1), one asymmetric carbon exists, and R form based on the asymmetric carbon (the following formula (1a)

Indicated by ) And S-form (formula (1b)

In the present invention, any enantiomer ratio can be used for the present compound (1).

  Pyraclostrobin, azoxystrobin, trifloxystrobin, metconazole, prothioconazole, triticonazole, tebuconazole, difenoconazole (Difenoconazole), ipconazole, thiophanate-methyl, fludioxonil, tolclofos-methyl, thiram, captan, carboxin, carboxin, boscalid) and thiabendazole are both known compounds. For example, 971 of “THE PESTICIDE MANUAL-15th EDITION (BCPC) ISBN 1901396188”. 62, 1167, 749, 965, 1182, 1072, 354, 663, 1128, 520, 1135, 1132, 154, 164, 121, and 1109, respectively. These compounds can be obtained from commercially available preparations or produced by known methods.

  In the composition of the present invention, when one or more bactericidal compounds selected from group (B) may be optionally added together with clothianidin and one or more bactericidal compounds selected from group (A). The content ratio is not particularly limited, but the total of one or more bactericidal compounds selected from the group (B) is usually 2 to 10000000 parts by weight, preferably 5 parts per 1000 parts by weight of clothianidin. ˜50000 parts by weight.

  In the composition of the present invention, when one or more bactericidal compounds selected from group (C) may be optionally added together with clothianidin and one or more bactericidal compounds selected from group (A). The content ratio is not particularly limited, but the total amount of one or more bactericidal compounds selected from the group (C) is usually 2 to 10000000 parts by weight, preferably 5 parts per 1000 parts by weight of clothianidin. ˜50000 parts by weight.

  In the composition of the present invention, when one or more bactericidal compounds selected from group (D) may be optionally added together with clothianidin and one or more bactericidal compounds selected from group (A). The content ratio is not particularly limited, but the total of one or more bactericidal compounds selected from the group (D) with respect to 1000 parts by weight of clothianidin is usually 2 to 10000000 parts by weight, preferably 5 parts. ˜50000 parts by weight.

  The total amount of clothianidin, the fungicidal compound selected from the group (A), and other insecticidal compounds and fungicidal compounds in the composition of the present invention is usually 0.1 to 99% by weight, preferably 0.2 to 90% by weight. More preferably, it is 1 to 80% by weight.

  Examples of solid carriers used in formulation include kaolin clay, attapulgite clay, bentonite, montmorillonite, acid clay, pyrophyllite, talc, diatomaceous earth, calcite, corn cob flour, walnut shell powder, etc. Natural organic materials, synthetic organic materials such as urea, salts such as calcium carbonate and ammonium sulfate, fine powders or granular materials made of synthetic inorganic materials such as synthetic silicon hydroxide, etc., and liquid carriers include, for example, xylene, alkylbenzene, methyl Aromatic hydrocarbons such as naphthalene, alcohols such as 2-propanol, ethylene glycol, propylene glycol and ethylene glycol monoethyl ether, ketones such as acetone, cyclohexanone and isophorone, vegetable oils such as soybean oil and cottonseed oil, petroleum fats Group hydrocarbon , Esters, dimethyl sulfoxide, acetonitrile and water.

  Examples of surfactants include anionic interfaces such as alkyl sulfate esters, alkylaryl sulfonates, dialkyl sulfosuccinates, polyoxyethylene alkylaryl ether phosphate esters, lignin sulfonates, naphthalene sulfonate formaldehyde polycondensates, and the like. Nonionic surfactants such as activators and polyoxyethylene alkyl aryl ethers, polyoxyethylene alkyl polyoxypropylene block copolymers, sorbitan fatty acid esters, and cationic surfactants such as alkyltrimethylammonium salts.

  Examples of other adjuvants for preparation include water-soluble polymers such as polyvinyl alcohol and polyvinyl pyrrolidone, gum arabic, alginic acid and salts thereof, polysaccharides such as CMC (carboxymethyl cellulose) and xanthan gum, aluminum magnesium silicate, alumina sol Inorganic substances such as preservatives, colorants and stabilizers such as PAP (isopropyl acid phosphate) and BHT.

  The composition of the present invention is intended to protect plants from damage by harmful organisms that injure plants such as feeding and sucking (for example, harmful arthropods such as harmful insects and harmful mites, and plant diseases). Can be used.

  Examples of harmful arthropods having the control effect of the composition of the present invention include the following.

Hemiptera: small brown planthopper (Laodelphax striatellus), brown planthopper (Nilaparvata lugens), Sejirounka (Sogatella furcifera) planthoppers such as, green rice leafhopper (Nephotettix cincticeps), Taiwan green rice leafhopper (Nephotettix virescens) leafhoppers such as, cotton aphid (Aphis gossypii) , Peaches aphids (Myzus persicae), radish aphids (Brevicoryne brassicae), tulip beetle aphids (Macrosiphum euphorbiae), potato beetle aphids (Aulacorthum solani), wheat Aphids such as aphids (Rhopalosiphum padi), citrus aphids (Toxoptera citricidus), Nezaa tentensata (Nezara antenata), moss aphids (Riptortus clavetus), claw helicopters Bugs such as Japanese larvae (Halyomorpha mista), Tarnished plant bugs (Lyus lineolaris), Triangularodes vaporiarum, Tobacco whiteflies (Bemisia tabacii) olii) and other whiteflies, Aonidiella aurantii, Santos scale insects (Comstockcaspis perniciosa), Citrus snow scale (Unaspis citris), Cerobipestrum (Ceroplastes rubenga) , Whales, etc .;
Lepidoptera: rice stem borer (Chilo suppressalis), Sankameiga (Tryporyza incertulas), leaf roller (Cnaphalocrocis medinalis), Watanomeiga (Notarcha derogata), Indian meal moth (Plodia interpunctella), the European corn borer (Ostrinia furnacalis), European corn borer (Ostrinia nubilaris), Japanese medusa such as Hellula undalis, Pediasia terterrulus, Spodoptera litura, Spodoptera exigua, P. genus of udaletia separata, moths of mamestra brassicae, genus agrotis ipsilon, genus esca (Grapholita molesta), Leguminivola glycinivolorella, Azusayamamushiga (Matsumuraeses azukivivora), Apple wolfberry (Adoxophyces harasca) ona magnanima), Mi someone summer fruit moth (Archips fuscocupreanus), codling moth (Cydia pomonella) Tortricidae such as, Chanohosoga (Caloptilia theivora), subfraction class, Shinkuiga such as peach fruit moth (Carposina niponensis) of the apple leaf miner (Phyllonorycter ringoneella), Rionetia genus Species of the genus Candida, Limantria, Euprocutis, etc., Suga (Plutella xylostella), Sputum, Pectinophora gossypiella, potato moth (Phtholimaea opercula), yphantria cunea) Arctiidae such as, clothes moth (Tinea translucens) Hirozukoga such as such;
Thysanoptera: western flower thrips (Frankliniella occidentalis), Minami thrips (Thrips parmi), yellow tea thrips (Scirtothrips dorsalis), green onion thrips (Thrips tabaci), Hirazuhanaazamiuma (Frankliniella intonsa), the tobacco thrips (Frankliniella fusca) such as Thrips, etc .;
Diptera: onion maggot (Hylemya antiqua), seedcorn maggot (Hylemya platura), rice leafminer (Agromyza oryzae), rice Hime leafminer (Hydrellia griseola), Inekimoguribae (Chlorops oryzae), leafminer such as beans leafminer (Liriomyza trifolii), melon fly (Dacus cucurbitae), fruit fly (Ceratitis capitata) and the like;
Coleoptera: beetle, Epilachna vigintioctopunctata (Epilachna vigintioctopunctata), cucurbit leaf beetle (Aulacophora femoralis), Kisujinomihamushi (Phyllotreta striolata), Inedorooimushi (Oulema oryzae), rice weevil (Echinocnemus squameus), rice water weevil (Lissorhoptrus oryzophilus), boll weevil (Anthonomus grandis), Azuki beetle (Callosobruchus chinensis), Shibahorusu weevil (Sphenophorus venatus), Japanese beetle (Popilia japonica), Douganebububu (Anomala cupre) ..), Corn rootworm fellow (Diabrotica spp), Colorado potato beetle (Leptinotarsa decemlineata), fellow of click beetles (Agriotes spp), cigarette beetle (Lasioderma serricorne) and the like;
Straight-eyed pests: Kelly (Grylotalpa africana), Oxya yezoensis, Oyana japonica, etc .;
Hymenopteran pests: Athalia rosae, Acrymyrme spp., Fire Ant (Solenopsis spp.), Etc .;

  Among the harmful arthropods, preferred examples include aphids, thrips, leafworms, bark beetles, Colorado potato beetles, beetles, scallops, cotton weevil, rice weevil, tobacco thrips, corn rootworm, etc. Can be mentioned.

Examples of the plant diseases having the control effect of the pest control composition of the present invention include the following.
Rice diseases: rice blast (Magnaporthe grisea), sesame leaf blight (Cochliobolus miyabeanus), blight (Rhizoctonia solani), idiotic seedling (Gibberella fujikuruoi).
Wheat diseases: powdery mildew (Erysiphe graminis), red mold disease (Fusarium gramaminerum, F. avenacerum, F. culmorum, Microdochium nitrid, red rust (Puccinia isp. (Microlectriella nivale), Snow rot microspora nuclear disease (Typhula sp.), Bare smut (Ustylago tritici), Tuna scab (Tilleletia carripe), Pseucercosporella morposis (Pseudocercosporella herposis) Blight (Stagonospo) a nodorum), Kimadarabyo (Pyrenophora tritici-repentis).
Diseases of barley: powdery mildew (Erysiphe graminis), red mold disease (Fusarium gramaminerum, F. avenacerum, F. culmorum, Microdochium nitrifle, black punishment) Ustilago nuda), cloud disease (Rhynchosporium secalis), reticular disease (Pyrenophora teres), spot disease (Cochliobolus sativus), leafy leaf disease (Pyrenophora graminea), and Rhizonia a.
Diseases of corn: smut (Ustilago maydis), sesame leaf blight (Cochliobolus heterostrohus), leprosy (Gloeocercospora sorgi), southern rust (Puccinia polysora), gray leaf spot disease Rhizoctonia solani due to seedling.

Diseases of citrus: Black spot disease (Diaporthe citri), common scab (Elsinoe fawceti), fruit rot (Penicillium digitatum, P. italicum), Phytophthora paraphysitica, Phytophthora or Phytophthora paraphysicor, Phytophthora or Phytophthora parathitosis.
Diseases of apples: Monilia mary, rot (Valsa ceratosperma), powdery mildew (Podospataera leukotrica), spotted leaf disease (Alternaria altanatal pest disease) Phytophthora catorum, brown spot disease (Diplocarpon mali), ring rot (Botryosphaeria berengeria).
Pear Diseases: Black Star Disease (Venturia nashicola, V. pirina), Black Spot Disease (Alternaria alternata Japan pearpathotype), Red Star Disease (Gymnosporangium haraeumum), Disease
Peach diseases: Monilinia fracticola, black scab (Cladosporium carpophilum), Phomopsis spoilage (Phomopsis sp.).
Grape diseases: black scab (Elsinoe ampelina), late rot (Glomerella cinulata), powdery mildew (Uncinula apelopidais), black rot (Gikonivaladi) .
Oyster diseases: Anthracnose (Gloeosporium kaki), deciduous leaf disease (Cercospora kaki, Mycosphaerella nawae).
Diseases of cucurbits: Anthracnose (Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), vine blight (Mycosphaerella meloniis), vine warp (Fusarium oxysporum), por disease (u) ), Seedling blight (Pythium sp.);
Diseases of tomato: Alternaria solani, leaf mold (Cladosporium fulvum), plague (Phytophthora infestans).
Diseases of eggplant: brown spot disease (Phomopsis vexans), powdery mildew (Erysiphe cichoacearum).
Diseases of cruciferous vegetables: black spot disease (Alternaria japonica), white spot disease (Cercosporella brassicae), clubroot (Plasmodiophora brassicae), downy mildew (Peronospora parasitica).
Diseases of leek: rust (Puccinia allii), downy mildew (Peronospora destructor).

Diseases of Soybean: Purpura (Cercospora kikuchii), Black spot (Elsinoe glycines), Black spot (Diaporthe phaseolum var. Sojae), Brown spot (Septoria glycines) Phytophthora sojae, Rhizoctonia solani caused by Rhizoctonia spp.
Kidney disease: Anthracnose (Colletotrichum lindemthianum).
Peanut disease: black astringency (Cercospora personata), brown spot (Cercospora arachidicola), white silkworm (Sclerotium rolfsii).
Pea disease: powdery mildew (Erysiphe pisi), root rot (Fusarium solani f. Sp. Pisi).
Potato diseases: Alternaria solani, Phytophthora infestans, Sputum rot septica, Spongosporia subteranean f.
Strawberry disease: powdery mildew (Sphaerotheca humuli), anthracnose (Glomerella singulata).
Tea diseases: net blast (Exobasidium reticulatum), white scab (Elsinoe leucospila), ring spot disease (Pestalotiosis sp.), Anthracnose (Colletotrichum theae-sinensis).
Tobacco Diseases: Alternaria longipes, powdery mildew (Erysiphe cichoracearum), anthracnose (Colletotrichum tabacum), downy mildew (Peronospora tabacina), plague
Rapeseed diseases: Sclerotinia sclerotiorum, Rhizoctonia solani, and Rhizoctonia solani.
Cotton diseases; Rhizoctonia solani and Fusarium oxysporum.
Diseases of sugar beet: brown spot disease (Cercospora beticola), leaf rot (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris), black root disease (Aphanomyces cochlioides).
Rose diseases: black spot (Diplocarpon rosae), powdery mildew (Sphaerotheca pannosa), downy mildew (Peronospora sparsa).
Diseases of chrysanthemum and asteraceae vegetables: downy mildew (Bremia lactucae), brown spot disease (Septoria chrysanthemi-indici), white rust (Puccinia horiana).
Diseases of various plants: Diseases caused by Pythium spp. (Phythium aphanidermatum, Pythium debarianum, Pythium graminicola, Pythium irregulare, Pythium ultimatum), Gray mold disease (Botritris botulint disease)
Radish disease: Alternaria brassicicola.
Diseases of Shiba: Sclerotinia homecarpa, Brown patch disease and Rhizotonia solani.
Banana disease: Sigatoka disease (Mycosphaerella fijiensis, Mycosphaerella musicola).
Sunflower disease: downy mildew (Plasmopara halstedii).
Aspergillus genus, Penicillium genus, Fusarium genus, Gibberella genus, Tricoderder genus, Thielaviopsis genus, Rhizopus genus, Mucor genus, Corticium genus, Poma genus, Rhizoctonia genus Disease.

  The composition of the present invention is used to control pests by applying to pests or places where pests live or where they may live.

  Places where pests inhabit You can live young or inhabited by plant foliage, plant seeds, plant bulbs. In addition, a bulb, a bulb, a rhizome, a tuber, and a root support body are mentioned in detail here with a bulb.

  The pest control method of the present invention is carried out by treating the composition of the present invention. Specifically, for example, treatment of plant foliage such as foliage spraying, seed disinfection and treatment of seed such as seed coat. And treatment of bulbs such as seed pods.

  Specific examples of the treatment method for the foliage of the plant in the pest control method of the present invention include a treatment method applied to the surface of the plant such as spraying foliage.

  Examples of the treatment method for seeds and the treatment method for bulbs in the control method of the present invention include, for example, a method of treating the seeds, bulbs, and the like of plants to be protected from pests. Specifically, for example, a small amount of the suspension of the composition of the present invention is sprayed on the seed surface or the surface of the bulb or sprayed on the seed surface or the surface of the bulb. Examples include a smearing process in which water is added or applied to seeds or bulbs as it is, a dipping process in which seeds are immersed in a solution of the composition of the present invention for a certain period of time, a film coating process, and a pellet coating process.

When treating the composition of the present invention to plants, the amount of treatment can be varied depending on the type of plant to be treated, the type and degree of occurrence of pests to be controlled, formulation form, treatment time, weather conditions, etc., but clothianidin The total amount of the fungicidal compound selected from the group (A) and other insecticidal compounds and fungicidal compounds is usually 1 to 5000 g, preferably ^{2 to} 400 g, per 10,000 m ² where the plant is cultivated.
Emulsions, wettable powders, flowables and the like are usually treated by diluting with water and spraying. In this case, the total concentration of clothianidin, the fungicidal compound selected from the group (A), and other insecticidal compounds and fungicidal compounds is usually 0.0001 to 3% by weight, preferably 0.0005 to 1% by weight. is there. Powders, granules, etc. are usually processed without dilution.
In the treatment of seeds, the total amount of clothianidin, a bactericidal compound selected from the group (A), and other insecticidal compounds and bactericidal compounds is usually 0.001 to 20 g, preferably 0. Applied at 01-5g.
In the treatment of bulbs, the total amount of clothianidin, a bactericidal compound selected from the group (A), and other insecticidal compounds and bactericidal compounds is usually 0.001 to 20 g, preferably 0. Applied at 01-5g.

The pest control method of the present invention can be used in agricultural land such as fields, paddy fields and fruit trees.
Further, the present invention can be used for controlling pests in the farmland in the farmland where the “plants” listed below are cultivated.
Agricultural crops: corn, rice, wheat, barley, rye, oat, sorghum, cotton, soybean, pea, green beans, groundnut, buckwheat, sugar beet, rapeseed, sunflower, sugarcane, tobacco, etc.
Vegetables: Eggplant vegetables (eggplant, tomatoes, peppers, peppers, potatoes, etc.), cucurbits vegetables (cucumbers, pumpkins, zucchini, watermelon, melon, squash, etc.), cruciferous vegetables (radish, turnip, horseradish, kohlrabi, Chinese cabbage) , Cabbage, mustard, broccoli, cauliflower, etc.), asteraceae vegetables (burdock, garlic, artichoke, lettuce, etc.), liliaceae vegetables (leek, onion, garlic, asparagus), celery family vegetables (carrot, parsley, celery, USA) Bowfish, etc.), red crustacean vegetables (spinach, chard, etc.), perilla vegetables (perilla, mint, basil, etc.), strawberries, sweet potatoes, yam, taros, etc.
Shiva,
Fruit trees; pears (apples, pears, Japanese pears, quince, quince, etc.), nuclear fruits (peaches, plums, nectarines, ume, sweet cherry, apricots, prunes, etc.), citrus (satsuma mandarin, orange, lemon, lime, grapefruit) ), Nuts (chestnut, walnut, hazel, almond, pistachio, cashew nut, macadamia nut, etc.), berries (blueberry, cranberry, blackberry, raspberry, etc.), grape, oyster, olive, loquat, banana, coffee, Date palm, coconut palm, etc.
Trees other than fruit trees: Cha, mulberry, flowering trees, street trees (ash, birch, dogwood, eucalyptus, ginkgo, lilac, maple, oak, poplar, redwood, fu, sycamore, zelkova, black bean, peach tree, Tsuga, rat, pine, Spruce, yew) etc.

  Among the plants, preferred examples include corn, wheat, soybean, cotton, rapeseed, sugar beet and the like.

The above “plant” refers to HPPD inhibitors such as isoxaflutol, ALS inhibitors such as imazetapyr and thifensulfuron methyl, EPSP synthetase inhibitors such as glyphosate, glutamine synthetase inhibitors such as glufosinate, cetoxydim and the like. Plants to which tolerance to herbicides such as acetyl CoA carboxylase inhibitor, bromoxynil, dicamba, 2,4-D, etc. are imparted by classical breeding methods or genetic recombination techniques are also included.
Examples of “plants” that have been given resistance by classical breeding methods include rapeseed, wheat, sunflower, and rice that are resistant to imidazolinone-based ALS-inhibiting herbicides such as imazetapil under the trade name Clearfield (registered trademark). Already sold. Similarly, there are soybeans that are resistant to sulfonylurea ALS-inhibiting herbicides such as thifensulfuron methyl by classical breeding methods, and are already sold under the trade name of STS soybeans. Similarly, SR corn and the like are examples of plants to which tolerance has been imparted to acetyl CoA carboxylase inhibitors such as trion oxime and aryloxyphenoxypropionic acid herbicides by classical breeding methods. Plants tolerant to acetyl CoA carboxylase inhibitors have been identified as Proceedings of the National Academy of Sciences of the United States of America (Proc. Natl. Acad. Sci. USA) 87, 7175-7179 (1990). A mutant acetyl CoA carboxylase resistant to an acetyl CoA carboxylase inhibitor has been reported in Weed Science 53, 728-746 (2005). A plant resistant to an acetyl-CoA carboxylase inhibitor can be produced by introducing a mutation into plant acetyl-CoA carboxylase or introducing a mutation associated with imparting resistance into the plant. Further, a base substitution mutation-introduced nucleic acid represented by chimera plastic technology (Gura T. 1999. Repairing the Genome's Spelling Mistakes. Science 285: 316-318.) Is introduced into plant cells, and then plant acetyl-CoA carboxylase is introduced. By introducing site-specific amino acid substitution mutations into genes, ALS genes, etc., plants resistant to acetyl CoA carboxylase inhibitors, ALS inhibitors, etc. can be created.

  Examples of plants that have been rendered resistant by genetic recombination techniques include glyphosate-resistant maize, soybean, cotton, rapeseed, and sugar beet varieties, which are already sold under trade names such as Roundup Ready (RoundupReady (registered trademark)) and Agriureture GT. Has been. Similarly, there are corn, soybean, cotton and rapeseed varieties that are resistant to glufosinate by genetic recombination technology, and are already sold under trade names such as Liberty Link (registered trademark). Similarly, bromoxynyl-resistant cotton by gene recombination technology is already sold under the trade name BXN.

The above “plant” includes, for example, a plant that can synthesize a selective toxin or the like known in the genus Bacillus using a gene recombination technique.
Toxins expressed in such genetically modified plants include insecticidal proteins derived from Bacillus cereus and Bacillus popirie; Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C derived from Bacillus thuringiensis Insecticidal proteins such as δ-endotoxin, VIP1, VIP2, VIP3 or VIP3A; nematode-derived insecticidal proteins; toxins produced by animals such as scorpion toxins, spider toxins, bee toxins or insect-specific neurotoxins; filamentous fungal toxins; plants Lectin; agglutinin; protease inhibitors such as trypsin inhibitor, serine protease inhibitor, patatin, cystatin, papain inhibitor; lysine, corn-RIP, abrin, ruffin, saporin, bryodin, etc. Ribosome inactivating protein (RIP); steroid metabolic enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glucosyltransferase, cholesterol oxidase; ecdysone inhibitor; HMG-CoA reductase; sodium channel, calcium channel inhibitor, etc. Ion channel inhibitor; juvenile hormone esterase; diuretic hormone receptor; stilbene synthase; bibenzyl synthase; chitinase; glucanase and the like.
Further, as toxins expressed in such genetically modified plants, Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, Cry9C, Cry34Ab, Cry35Ab and other δ-endotoxin proteins, VIP1, VIP2, VIP3 or VIP3A, etc. Also included are insecticidal protein hybrid toxins, partially defective toxins, and modified toxins. Hybrid toxins are produced by new combinations of different domains of these proteins using recombinant techniques. As a toxin lacking a part, Cry1Ab lacking a part of the amino acid sequence is known. In the modified toxin, one or more amino acids of the natural toxin are substituted.
Examples of these toxins and recombinant plants capable of synthesizing these toxins are EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878. , WO 03/052073, and the like.
Toxins contained in these recombinant plants particularly confer resistance to Coleoptera, Hemiptera pests, Diptera pests, Lepidoptera pests and nematodes.

  In addition, genetically modified plants that contain one or more insecticidal pest resistance genes and express one or more toxins are already known and some are commercially available. Examples of these transgenic plants include YieldGard® (a corn variety that expresses Cry1Ab toxin), YieldGuard Rootworm® (a corn variety that expresses Cry3Bb1 toxin), YieldGard Plus® (Cry1Ab and Cry3Bb1) Corn varieties expressing toxin), Herculex I® (corn varieties expressing phosphinotricin N-acetyltransferase (PAT) to confer resistance to Cry1Fa2 toxin and glufosinate), NuCOTN33B® ( Cotton varieties expressing Cry1Ac toxin), Bollgard I (registered trademark) (cotton varieties expressing Cry1Ac toxin), Bollgard II (registered trademark) (Cotton varieties expressing Cry1Ac and Cry2Ab toxins), VIPCOT (registered trademark) (cotton varieties expressing VIP toxins), NewLeaf (registered trademark) (potato varieties expressing Cry3A toxin), NatureGard (registered trademark) Agurisure ( (Registered trademark) GT Advantage (GA21 glyphosate resistant trait), Agurisure (registered trademark) CB Advantage (Bt11 corn borer (CB) trait), Protecta (registered trademark), and the like.

The “plant” includes those imparted with an ability to produce an anti-pathogenic substance having a selective action using a gene recombination technique.
PR proteins and the like are known as examples of anti-pathogenic substances (PRPs, EP-A-0 392 225). Such anti-pathogenic substances and genetically modified plants that produce them are described in EP-A-0 392 225, WO 95/33818, EP-A-0 353 191 and the like.
Examples of anti-pathogenic substances expressed in such genetically modified plants include, for example, sodium channel inhibitors, calcium channel inhibitors (KP1, KP4, KP6 toxins produced by viruses, etc.). Ion channel inhibitors; stilbene synthase; bibenzyl synthase; chitinase; glucanase; PR protein; peptide antibiotics, heterocyclic antibiotics, protein factors involved in plant disease resistance (called plant disease resistance genes, WO 03/000906)) and the like, and the like, and the like, which are produced by microorganisms. Such anti-pathogenic substances and genetically modified plants that produce them are described in EP-A-0392225, WO95 / 33818, EP-A-0353191, and the like.

  The above “plant” includes plants imparted with useful traits such as oil component modification and amino acid content enhancing traits using genetic recombination techniques. Examples include VISTIVE (registered trademark) (low linolenic soybeans with reduced linolenic content) or high-lysine (high-oil) corn (corn with increased lysine or oil content).

  In addition, the above-mentioned classic herbicide traits or herbicide resistance genes, insecticidal pest resistance genes, anti-pathogenic substance production genes, oil traits modification, amino acid content enhancement traits, etc. Combined stack varieties are also included.

  Hereinafter, the present invention will be described in more detail with formulation examples, application examples, and test examples, but the present invention is not limited to the following examples. In the following examples, parts represent parts by weight unless otherwise specified.

Formulation Example 1
A mixture of 5.0 parts of clothianidin, 10 parts of mancozeb, 1.5 parts of sorbitan trioleate and 2 parts of polyvinyl alcohol and finely pulverized by a wet pulverization method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and further 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 2
Mix 5.0 parts of clothianidin, 10 parts of mancozeb, 1.0 part of thiophanate methyl, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol. After pulverization, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added thereto to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed to obtain a flowable preparation. obtain.

Formulation Example 3
Mix 5.0 parts of clothianidin, 10 parts of mancozeb, 4.0 parts of fludioxonil, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol. After pulverization, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added thereto to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed to obtain a flowable preparation. obtain.

Formulation Example 4
Mix 5.0 parts of clothianidin, 10 parts of mefenoxam, 10 parts of metconazole, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, and pulverize them by a wet grinding method. Thereafter, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added thereto to make the total amount 90 parts, and further 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Examples 5-18
A flowable formulation is obtained by performing the same operation as in Formulation Example 4 except that the compound described in [Table 1] and the amount used are used in place of 10 parts of metconazole.

Formulation Example 19
28 parts aqueous solution containing 5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts ethaboxam, 5 parts metconazole, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol. After mixing and pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol. In addition, stirring and mixing are performed to obtain a flowable preparation.

Formulation Example 20
5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts ethaboxam, 5 parts racemic compound (1), 1.5 parts sorbitan trioleate, and polyvinyl alcohol 2 After mixing 28 parts of an aqueous solution containing parts and finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 parts of xanthan gum and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. 10 parts of propylene glycol is added and mixed by stirring to obtain a flowable preparation.

Formulation Example 21
A flowable preparation is obtained by conducting the same operation as in Preparation Example 20, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 22
28 parts aqueous solution containing clothianidin 5 parts, boscalid 10 parts, pyraclostrobin 5 parts, ethaboxam 10 parts, tolcrofosmethyl 5 parts, sorbitan trioleate 1.5 parts, and polyvinyl alcohol 2 parts And an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and further 10 parts of propylene glycol. And stirring and mixing to obtain a flowable preparation.

Formulation Example 23
28 parts aqueous solution containing 5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts metalaxyl, 5 parts metconazole, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol. After mixing and pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol. In addition, stirring and mixing are performed to obtain a flowable preparation.

Formulation Example 24
A flowable preparation is obtained by performing the same operation as in Preparation Example 23 except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 25
Clothianidin 5 parts, boscalid 10 parts, pyraclostrobin 5 parts, metalaxyl 5 parts, racemate of this compound (1) 5 parts, sorbitan trioleate 1.5 parts, and polyvinyl alcohol 2 After mixing 28 parts of an aqueous solution containing parts and finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 parts of xanthan gum and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. 10 parts of propylene glycol is added and mixed by stirring to obtain a flowable preparation.

Formulation Example 26
A flowable formulation is obtained by performing the same operation as in Formulation Example 25 except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 27
A flowable preparation is obtained by conducting the same operation as in Preparation Example 25 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 28
A flowable preparation is obtained by conducting the same operation as in Preparation Example 26 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 29
28 parts aqueous solution containing 5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts metalaxyl, 10 parts tolcrophos methyl, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol And an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and further 10 parts of propylene glycol. And stirring and mixing to obtain a flowable preparation.

Formulation Example 30
A flowable formulation is obtained by performing the same operation as in Formulation Example 29, except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 31
5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts metalaxyl, 5 parts metconazole, 5 parts ethaboxam, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol 28 parts of an aqueous solution containing was mixed and finely pulverized by a wet pulverization method, and then an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate was added to make a total amount of 90 parts. Add 10 parts of water and stir and mix to obtain a flowable formulation.

Formulation Example 32
A flowable formulation is obtained by performing the same operation as in Formulation Example 31, except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 33
Clothianidin 5 parts, boscalid 10 parts, pyraclostrobin 5 parts, metalaxyl 5 parts, racemate of this compound (1) 5 parts, ethaboxam 5 parts, sorbitan trioleate 1.5 parts, and After mixing 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol and finely pulverizing it by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate was added thereto to make a total amount. 90 parts, and further 10 parts of propylene glycol is added and mixed by stirring to obtain a flowable preparation.

Formulation Example 34
A flowable formulation is obtained by performing the same operation as in Formulation Example 33 except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 35
A flowable preparation is obtained by conducting the same operation as in Preparation Example 33, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 36
A flowable preparation is obtained by conducting the same operation as in Preparation Example 34, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 37
5 parts clothianidin, 10 parts boscalid, 5 parts pyraclostrobin, 5 parts metalaxyl, 10 parts tolcrofosmethyl, 5 parts ethaboxam, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol After mixing 28 parts of an aqueous solution containing 30 parts and finely pulverizing with a wet grinding method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts. Add 10 parts of glycol and stir and mix to obtain a flowable formulation.

Formulation Example 38
A flowable formulation is obtained by conducting the same operation as in Formulation Example 37, except that 2 parts of mefenoxam is used instead of 5 parts of metalaxyl.

Formulation Example 39
5 parts of clothianidin, 5 parts of metalaxyl, 10 parts of thiuram, 3 parts of ipconazole, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol are mixed and wet-grinded. After finely pulverizing, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed to obtain a flowable preparation. Get.

Formulation Example 40
A flowable preparation is obtained by performing the same operation as in Preparation Example 39, except that 10 parts of trifloxystrobin is used instead of 3 parts of ipconazole.

Formulation Example 41
Mix 5 parts of clothianidin, 2 parts of mefenoxam, 10 parts of trifloxystrobin, 10 parts of thiuram, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, and wet. After finely pulverizing by the pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol is added and stirred and mixed. And obtain a flowable formulation.

Formulation Example 42
Mix 5 parts of clothianidin, 2 parts of mefenoxam, 10 parts of trifloxystrobin, 1 part of metconazole, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol. After finely pulverizing by the pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol is added and stirred and mixed. And obtain a flowable formulation.

Formulation Example 43
An aqueous solution containing 5 parts clothianidin, 2 parts mefenoxam, 10 parts trifloxystrobin, 1 part racemic compound (1), 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol. 28 parts are mixed and finely pulverized by a wet pulverization method, and then an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total of 90 parts, and further propylene glycol. Add 10 parts and stir and mix to obtain a flowable formulation.

Formulation Example 44
A flowable preparation is obtained by conducting the same operation as in Preparation Example 43, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 45
An aqueous solution containing 5 parts clothianidin, 2 parts mephenoxam, 1 part racemate of the compound (1), 10 parts azoxystrobin, 1.5 parts sorbitan trioleate, and 2 parts polyvinyl alcohol. 28 parts are mixed and finely pulverized by a wet pulverization method, and then an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total of 90 parts, and further propylene glycol. Add 10 parts and stir and mix to obtain a flowable formulation.

Formulation Example 46
A flowable preparation is obtained by conducting the same operation as in Preparation Example 45, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 47
28 parts of an aqueous solution containing 5 parts of clothianidin, 2 parts of mephenoxam, 1 part of the racemate of the compound (1), 10 parts of thiabendazole, 1.5 parts of sorbitan trioleate, and 2 parts of polyvinyl alcohol. After mixing and pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol. In addition, stirring and mixing are performed to obtain a flowable preparation.

Formulation Example 48
A flowable preparation is obtained by conducting the same operation as in Preparation Example 47, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 49
Mix 5 parts of clothianidin, 2 parts of mefenoxam, 5 parts of tolcrofosmethyl, 10 parts of trifloxystrobin, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, After finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts, and 10 parts of propylene glycol is further added and stirred. Mix to obtain a flowable formulation.

Formulation Example 50
Mix 5 parts of clothianidin, 2 parts of mephenoxam, 5 parts of tolcrofosmethyl, 10 parts of azoxystrobin, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol, After finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts, and 10 parts of propylene glycol is further added and stirred. Mix to obtain a flowable formulation.

Formulation Example 51
Wet grinding method by mixing 5 parts clothianidin, 2 parts mefenoxam, 5 parts torquelofosmethyl, 10 parts thiabendazole, 1.5 parts sorbitan trioleate, and 28 parts aqueous solution containing 2 parts polyvinyl alcohol. After adding the aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate, the total amount is 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed. A formulation is obtained.

Formulation Example 52
5 parts clothianidin, 5 parts metalaxyl, 5 parts ethaboxam, 10 parts racemic compound (1), 1 part trifloxystrobin, 1.5 parts sorbitan trioleate, and polyvinyl alcohol After mixing 28 parts of an aqueous solution containing 2 parts and finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate was added to make the total amount 90 parts, Further, 10 parts of propylene glycol is added and mixed by stirring to obtain a flowable preparation.

Formulation Example 53
A flowable preparation is obtained by conducting the same operation as in Preparation Example 52 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 54
5 parts clothianidin, 5 parts metalaxyl, 5 parts ethaboxam, 10 parts racemic compound (1), 1 part azoxystrobin, 1.5 parts sorbitan trioleate, and polyvinyl alcohol After mixing 28 parts of an aqueous solution containing 2 parts and finely pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate was added to make the total amount 90 parts, Further, 10 parts of propylene glycol is added and mixed by stirring to obtain a flowable preparation.

Formulation Example 55
A flowable preparation is obtained by conducting the same operation as in Preparation Example 54, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 56
5 parts of clothianidin, 2 parts of mefenoxam, 3 parts of ipconazole, 10 parts of thiuram, 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol are mixed and wet-ground. After finely pulverizing, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed to obtain a flowable preparation. Get.

Formulation Example 57
2 parts of clothianidin, 2 parts of mefenoxam, 3 parts of ipconazole, 1 part of racemic compound (1), 1.5 parts of sorbitan trioleate, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol After mixing and pulverizing by a wet pulverization method, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make the total amount 90 parts, and further 10 parts of propylene glycol. In addition, stirring and mixing are performed to obtain a flowable preparation.

Formulation Example 58
A flowable preparation is obtained by conducting the same operation as in Preparation Example 57, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 59
Wet grinding method by mixing 5 parts clothianidin, 2 parts mefenoxam, 3 parts ipconazole, 5 parts tolcrophosmethyl, 1.5 parts sorbitan trioleate, and 28 parts aqueous solution containing 2 parts polyvinyl alcohol. After adding the aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate, the total amount is 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed. A formulation is obtained.

Formulation Example 60
5 parts of clothianidin, 1 part of the present compound (1), 1 part of metconazole, 5 parts of metalaxyl, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet grinding method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts in total, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 61
A flowable preparation is obtained by conducting the same operation as in Preparation Example 60, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 62
Mix 5 parts of clothianidin, 1 part of the present compound (1), 1 part of metconazole, 5 parts of metalaxyl, 5 parts of ethaboxam, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol. After pulverization, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added thereto to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred and mixed to obtain a flowable preparation. obtain.

Formulation Example 63
A flowable preparation is obtained by conducting the same operation as in Preparation Example 62 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 64
5 parts of clothianidin, 1 part of the present compound (1), 1 part of metconazole, 5 parts of ethaboxam, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet grinding method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and further 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 65
A flowable preparation is obtained by conducting the same operation as in Preparation Example 64, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 66
5 parts of clothianidin, 5 parts of ethaboxam, 10 parts of difenoconazole, 10 parts of metconazole, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet grinding method. An aqueous solution containing 05 parts and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 67
A flowable formulation is obtained by performing the same operation as in Formulation Example 66, except that 5 parts of metalaxyl is used instead of ethaboxam.

Formulation Example 68
A flowable formulation is obtained by performing the same operation as in Formulation Example 66 except that 10 parts of mefenoxam is used in place of ethaboxam.

Formulation Examples 69-74
A flowable formulation is obtained by conducting the same operation as in Formulation Example 66 except that the compound described in [Table 2] and the amount used are used instead of 10 parts of metconazole.

Formulation Example 75
5 parts of clothianidin, 5 parts of ethaboxam, 10 parts of difenoconazole, 5 parts of metalaxyl, 10 parts of metconazole, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet grinding method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and further 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Examples 76-81
A flowable formulation is obtained by conducting the same operation as in Formulation Example 75 except that the compound described in [Table 3] and the amount used are used in place of 10 parts of metconazole.

Formulation Example 82
5 parts of clothianidin, 10 parts of ipconazole, 10 parts of boscalid, 5 parts of an aqueous solution containing 5 parts of pyraclostrobin, and 2 parts of polyvinyl alcohol were mixed and pulverized by a wet pulverization method. An aqueous solution containing .05 parts and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 83
5 parts of clothianidin, 10 parts of ipconazole, 10 parts of boscalid, 5 parts of pyraclostrobin, 5 parts of metalaxyl, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet grinding method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts in total, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 84
A flowable formulation is obtained by performing the same operation as in Formulation Example 83, except that 10 parts of mefenoxam is added instead of metalaxyl.

Formulation Example 85
A flowable formulation is obtained by performing the same operation as in Formulation Example 83, except that 5 parts of ethaboxam is added instead of metalaxyl.

Formulation Example 86
Mix 5 parts of clothianidin, 10 parts of ipconazole, 10 parts of boscalid, 5 parts of pyraclostrobin, 5 parts of metalaxyl, 5 parts of ethaboxam, and 2 parts of polyvinyl alcohol, and pulverize them by wet grinding. After that, an aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added thereto to make a total amount of 90 parts, and further 10 parts of propylene glycol is added and stirred to obtain a flowable preparation. .

Formulation Example 87
5 parts of clothianidin, 10 parts of ipconazole, 10 parts of trifloxystrobin, and 28 parts of an aqueous solution containing 2 parts of polyvinyl alcohol were mixed and pulverized by a wet pulverization method, and then 0.05 parts of xanthan gum and An aqueous solution containing 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 88
After mixing 28 parts of an aqueous solution containing clothianidin 5 parts, ipconazole 10 parts, trifloxystrobin 10 parts, metalaxyl 5 parts, and polyvinyl alcohol 2 parts, and then finely pulverized by a wet pulverization method, xanthan gum 0 An aqueous solution containing .05 parts and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 89
A flowable formulation is obtained by performing the same operation as in Formulation Example 88, except that 10 parts of mefenoxam is added instead of metalaxyl.

Formulation Example 90
A flowable formulation is obtained by performing the same operation as in Formulation Example 88, except that 5 parts of ethaboxam is added instead of metalaxyl.

Formulation Example 91
After mixing 5 parts of clothianidin, 10 parts of ipconazole, 10 parts of trifloxystrobin, 5 parts of metalaxyl, 5 parts of ethaboxam, and 2 parts of polyvinyl alcohol, this was pulverized by a wet pulverization method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts in total, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 92
After mixing 28 parts of an aqueous solution containing 5 parts of clothianidin, 10 parts of ipconazole, 10 parts of azoxystrobin, and 2 parts of polyvinyl alcohol, and finely pulverized by a wet pulverization method, 0.05 part of xanthan gum and An aqueous solution containing 0.1 part of aluminum magnesium silicate is added to make a total amount of 90 parts, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 93
28 parts of an aqueous solution containing 5 parts of clothianidin, 10 parts of ipconazole, 10 parts of azoxystrobin, 5 parts of metalaxyl and 2 parts of polyvinyl alcohol were mixed and pulverized by a wet pulverization method. An aqueous solution containing .05 parts and 0.1 parts of aluminum magnesium silicate is added to make a total amount of 90 parts. Further, 10 parts of propylene glycol is added and stirred to obtain a flowable preparation.

Formulation Example 94
A flowable formulation is obtained by performing the same operation as in Formulation Example 93, except that 10 parts of mefenoxam is added instead of metalaxyl.

Formulation Example 95
A flowable formulation is obtained by performing the same operation as in Formulation Example 93, except that 5 parts of ethaboxam is added instead of metalaxyl.

Formulation Example 96
A mixture of 5 parts of clothianidin, 10 parts of ipconazole, 10 parts of azoxystrobin, 5 parts of metalaxyl, 5 parts of ethaboxam, and 2 parts of polyvinyl alcohol was mixed and pulverized by a wet grinding method. An aqueous solution containing 0.05 part of xanthan gum and 0.1 part of aluminum magnesium silicate is added to make 90 parts in total, and 10 parts of propylene glycol is further added and stirred to obtain a flowable preparation.

Formulation Example 97
10 parts of clothianidin, 2.0 parts of mancozeb, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water are mixed to make a total amount of 100 parts. A flowable preparation is obtained by pulverization with

Formulation Example 98
Mix 10 parts of clothianidin, 2.0 parts of mancozeb, 0.8 part of thiophanate methyl, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water. The flowable preparation is obtained by making 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 99
Mix 10 parts of clothianidin, 2.0 parts of mancozeb, 0.8 part of fludioxonil, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water. The flowable preparation is obtained by making 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 100
Mix 10 parts of clothianidin, 0.16 part of mephenoxam, 0.4 part of metconazole, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water. The flowable preparation is obtained by making 100 parts and finely pulverizing by a wet pulverization method.

Formulation Examples 101-114
A flowable formulation is obtained by performing the same operation as in Formulation Example 100 except that the compound described in [Table 4] and the amount used are used instead of 0.4 part of metconazole.

Formulation Example 115
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts ethaboxam, 0.2 parts metconazole, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt ( Weight ratio 1: 1) 35 parts of water and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 116
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts ethaboxam, 0.2 parts racemic compound (1), white carbon and polyoxyethylene alkyl ether A flowable preparation is obtained by mixing 35 parts of a mixture with a sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 117
A flowable preparation is obtained by conducting the same operation as in Preparation Example 116, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 118
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts ethaboxam, 0.4 parts tolcrofosmethyl, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (Weight ratio 1: 1) 35 parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 119
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts metalaxyl, 0.2 parts metconazole, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt ( Weight ratio 1: 1) 35 parts of water and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 120
A flowable preparation is obtained by performing the same operation as in Preparation Example 119, except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 121
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts metalaxyl, 0.2 parts racemic compound (1), white carbon and polyoxyethylene alkyl ether A flowable preparation is obtained by mixing 35 parts of a mixture with a sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 122
A flowable formulation is obtained by performing the same operation as in Formulation Example 121 except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 123
A flowable preparation is obtained by conducting the same operation as in Preparation Example 121 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 124
A flowable formulation is obtained by conducting the same operation as in Formulation Example 122, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 125
10 parts of clothianidin, 0.2 parts of boscalid, 0.4 parts of pyraclostrobin, 0.4 parts of metalaxyl, 0.4 parts of tolcrophosmethyl, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (Weight ratio 1: 1) 35 parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 126
A flowable formulation is obtained by performing the same operation as in Formulation Example 125, except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 127
10 parts of clothianidin, 0.2 parts of boscalid, 0.4 parts of pyraclostrobin, 0.4 parts of metalaxyl, 0.2 parts of metconazole, 0.4 parts of ethaboxam, white carbon and polyoxyethylene alkyl ether A flowable preparation is obtained by mixing 35 parts of a mixture with a sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 128
A flowable formulation is obtained by conducting the same operation as in Formulation Example 127, except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 129
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts metalaxyl, 0.2 parts racemic compound (1), 0.4 parts ethaboxam, white A flowable preparation is obtained by mixing 35 parts of a mixture of carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 130
A flowable formulation is obtained by conducting the same operation as in Formulation Example 129, except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 131
A flowable preparation is obtained by conducting the same operation as in Preparation Example 129, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 132
A flowable preparation is obtained by conducting the same operation as in Preparation Example 130, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 133
10 parts clothianidin, 0.2 parts boscalid, 0.4 parts pyraclostrobin, 0.4 parts metalaxyl, 0.4 parts tolcrofosmethyl, 0.4 parts ethaboxam, white carbon and polyoxyethylene alkyl A flowable preparation is obtained by mixing 35 parts of a mixture with an ether sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 134
A flowable formulation is obtained by performing the same operation as in Formulation Example 133, except that 0.16 part of mefenoxam is used instead of 0.4 part of metalaxyl.

Formulation Example 135
Clothianidin 10 parts, metalaxyl 0.5 parts, thiuram 0.4 parts, ipconazole 0.6 parts, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) 35 parts, And water are mixed to make a total amount of 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 136
A flowable preparation is obtained by performing the same operation as in Preparation Example 135, except that 0.2 part of trifloxystrobin is used instead of 0.6 part of ipconazole.

Formulation Example 137
10 parts of clothianidin, 0.2 parts of mefenoxam, 0.2 parts of trifloxystrobin, 0.4 parts of thiuram, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 138
10 parts of clothianidin, 0.2 parts of mefenoxam, 0.2 parts of trifloxystrobin, 0.4 parts of metconazole, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 139
10 parts of clothianidin, 0.2 parts of mefenoxam, 0.2 parts of trifloxystrobin, 0.4 parts of racemic compound (1), a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (Weight ratio 1: 1) 35 parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 140
A flowable formulation is obtained by conducting the same operation as in Formulation Example 139 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 141
10 parts of clothianidin, 0.2 parts of mefenoxam, 0.4 parts of racemic compound (1), 0.2 parts of azoxystrobin, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (Weight ratio 1: 1) 35 parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 142
A flowable formulation is obtained by conducting the same operation as in Formulation Example 141 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 143
10 parts of clothianidin, 0.2 parts of mefenoxam, 0.4 parts of racemic compound (1), 1.0 part of thiabendazole, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio) 1: 1) 35 parts of water and water are mixed to make a total amount of 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 144
A flowable preparation is obtained by conducting the same operation as in Preparation Example 143, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 145
10 parts of clothianidin, 0.4 parts of mefenoxam, 0.4 parts of tolcrofosmethyl, 0.2 part of trifloxystrobin, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) 35 Parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 146
10 parts of clothianidin, 0.4 parts of mefenoxam, 0.4 parts of tolcrofosmethyl, 0.2 part of azoxystrobin, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 147
10 parts of clothianidin, 0.4 parts of mefenoxam, 0.4 parts of tolcrofosmethyl, 1.0 part of thiabendazole, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) , And water to make the total amount 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 148
10 parts clothianidin, 1.0 part metalaxyl, 1.0 part ethaboxam, 2.0 parts racemic compound (1), 1.0 part trifloxystrobin, white carbon and polyoxyethylene alkyl A flowable preparation is obtained by mixing 35 parts of a mixture with an ether sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 149
A flowable preparation is obtained by conducting the same operation as in Preparation Example 148, except that the R form of (1) is used instead of the racemic form of the present compound (1).

Formulation Example 150
10 parts clothianidin, 1.0 part metalaxyl, 1.0 part ethaboxam, 2.0 parts racemic compound (1), 1.0 part azoxystrobin, white carbon and polyoxyethylene alkyl A flowable preparation is obtained by mixing 35 parts of a mixture with an ether sulfate ammonium salt (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 151
A flowable formulation is obtained by conducting the same operation as in Formulation Example 119, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 152
Clothianidin 10 parts, mefenoxam 0.5 parts, ipconazole 1.5 parts, thiuram 1.0 parts 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and A flowable preparation is obtained by mixing water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 153
10 parts clothianidin, 0.5 parts mephenoxam, 1.5 parts ipconazole, 2.0 parts racemic compound (1), a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight percentage) 1: 1) 35 parts of water and water are mixed to make a total amount of 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 154
A flowable formulation is obtained by conducting the same operation as in Formulation Example 153 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 155
10 parts of clothianidin, 0.5 parts of mephenoxam, 1.5 parts of ipconazole, 1.0 part of tolcrofosmethyl, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) , And water to make the total amount 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 156
10 parts of clothianidin, 0.4 part of the present compound (1), 0.1 part of metconazole, 0.2 part of metalaxyl, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 157
A flowable formulation is obtained by conducting the same operation as in Formulation Example 156 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 158
10 parts of clothianidin, 0.4 part of the present compound (1), 0.1 part of metconazole, 0.2 part of metalaxyl, 0.2 part of ethaboxam, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (Weight ratio 1: 1) 35 parts and water are mixed to make the total amount 100 parts, and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 159
A flowable formulation is obtained by conducting the same operation as in Formulation Example 158, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 160
10 parts of clothianidin, 0.4 part of the present compound (1), 0.2 part of metconazole, 0.4 part of ethaboxam, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 161
A flowable preparation is obtained by conducting the same operation as in Preparation Example 106, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 162
10 parts of clothianidin, 0.4 parts of ethaboxam, 0.8 parts of difenoconazole, 0.4 parts of metconazole, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and A flowable preparation is obtained by mixing water to make a total amount of 100 parts and finely pulverizing by a wet pulverization method.

Formulation Example 163
A flowable formulation is obtained by performing the same operation as in Formulation Example 162, except that 0.4 part of metalaxyl is used instead of ethaboxam.

Formulation Example 164
A flowable formulation is obtained by performing the same operation as in Formulation Example 162, except that 0.16 part of mefenoxam is used instead of ethaboxam.

Formulation Examples 165 to 170
A flowable formulation is obtained by performing the same operation as in Formulation Example 162, except that the compound described in [Table 5] and the amount used are used instead of 0.4 part of metconazole.

Formulation Example 171
10 parts of clothianidin, 0.4 parts of ethaboxam, 0.8 parts of difenoconazole, 0.4 parts of metalaxyl, 0.4 parts of metconazole, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts, and finely pulverizing by a wet pulverization method.

Formulation Examples 172 to 177
A flowable formulation is obtained by conducting the same operation as in Formulation Example 171 except that the compound described in [Table 6] and the amount used are used instead of 0.4 part of metconazole.

Formulation Example 178
10 parts of clothianidin, 0.6 part of ipconazole, 0.2 part of boscalid, 0.4 part of pyraclostrobin, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), And water are mixed to make a total amount of 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 179
10 parts of clothianidin, 0.6 part of ipconazole, 0.2 part of boscalid, 0.4 part of pyraclostrobin, 0.4 part of metalaxyl, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts, and finely pulverizing by a wet pulverization method.

Formulation Example 180
A flowable formulation is obtained by conducting the same operation as in Formulation Example 179, except that 0.16 part of mefenoxam is added instead of metalaxyl.

Formulation Example 181
A flowable formulation is obtained by performing the same operation as in Formulation Example 179 except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 182
10 parts of clothianidin, 0.6 parts of ipconazole, 0.2 parts of boscalid, 0.4 parts of pyraclostrobin, 0.4 parts of metalaxyl, 0.4 parts of ethaboxam, white carbon and polyoxyethylene alkyl ether sulfate ammonium salt A flowable preparation is obtained by mixing 35 parts of the above mixture (weight ratio 1: 1) and water to make a total amount of 100 parts and finely pulverizing it by a wet pulverization method.

Formulation Example 183
Mix 10 parts of clothianidin, 0.6 part of ipconazole, 0.2 part of trifloxystrobin, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water to make a total amount. Is made into 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 184
10 parts of clothianidin, 0.6 parts of ipconazole, 0.2 parts of trifloxystrobin, 0.4 parts of metalaxyl, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), And water are mixed to make a total amount of 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 185
A flowable formulation is obtained by performing the same operation as in Formulation Example 184, except that 0.16 part of mefenoxam is added instead of metalaxyl.

Formulation Example 186
A flowable formulation is obtained by performing the same operation as in Formulation Example 184 except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 187
10 parts of clothianidin, 0.6 part of ipconazole, 0.2 part of trifloxystrobin, 0.4 part of metalaxyl, 0.4 part of ethaboxam, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts, and finely pulverizing by a wet pulverization method.

Formulation Example 188
Mix 10 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), and water to make a total amount. Is made into 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 189
10 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 0.4 part of metalaxyl, 35 parts of a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1: 1), And water are mixed to make a total amount of 100 parts and finely pulverized by a wet pulverization method to obtain a flowable preparation.

Formulation Example 190
A flowable formulation is obtained by performing the same operation as in Formulation Example 189, except that 0.16 part of mefenoxam is added instead of metalaxyl.

Formulation Example 191
A flowable formulation is obtained by performing the same operation as in Formulation Example 189, except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 192
10 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 0.4 part of metalaxyl, 0.4 part of ethaboxam, a mixture of white carbon and polyoxyethylene alkyl ether sulfate ammonium salt (weight ratio 1 1) A flowable preparation is obtained by mixing 35 parts and water to make a total amount of 100 parts, and finely pulverizing by a wet pulverization method.

Formulation Example 193
By thoroughly mixing 20 parts of clothianidin, 8.0 parts of mancozeb, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide, 100 parts of wettable powder is obtained.

Formulation Example 194
20 parts of clothianidin, 8.0 parts of mancozeb, 4.0 parts of thiophanate methyl, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and 100 parts of wettable powder by thoroughly mixing the remainder of the synthetic hydrous hydroxide Get.

Formulation Example 195
20 parts of clothianidin, 8.0 parts of mancozeb, 4.0 parts of fludioxonil, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and 100 parts of wettable powder by thoroughly mixing the remainder of the synthetic silicon hydroxide Get.

Formulation Example 196
20 parts of clothianidin, 1.6 parts of mefenoxam, 1.6 parts of metconazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remaining part of the synthetic silicon hydrous oxide Get.

Formulation Examples 197 to 210
The wettable powder is obtained by conducting the same operation as in Formulation Example 196 except that the compound described in [Table 7] and the amount used were used instead of 1.6 parts of metconazole.

Formulation Example 211
20 parts clothianidin, 1.6 parts boscalid, 0.8 parts pyraclostrobin, 0.8 parts ethaboxam, 1.6 parts metconazole, 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and synthetic 100 parts of wettable powder is obtained by thoroughly grinding and mixing the remaining hydrous silicon oxide.

Formulation Example 212
Clothianidin 20 parts, boscalid 1.6 parts, pyraclostrobin 0.8 parts, ethaboxam 0.8 parts, racemate of this compound (1) 1.6 parts, lignin calcium sulfonate 3 parts, lauryl 100 parts of wettable powder is obtained by thoroughly grinding and mixing 2 parts of sodium sulfate and the remainder of the synthetic hydrous silicon oxide.

Formulation Example 213
The wettable powder is obtained by conducting the same operation as in Formulation Example 212 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 214
20 parts clothianidin, 1.6 parts boscalid, 0.8 parts pyraclostrobin, 0.8 parts ethaboxam, 4.0 parts tolcrophos methyl, 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 215
20 parts clothianidin, 1.6 parts boscalid, 0.8 parts pyraclostrobin, 0.8 parts metalaxyl, 1.6 parts metconazole, 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and synthesis 100 parts of wettable powder is obtained by thoroughly grinding and mixing the remaining hydrous silicon oxide.

Formulation Example 216
The wettable powder is obtained by conducting the same operation as in Formulation Example 215 except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 217
20 parts clothianidin, 1.6 parts boscalid, 0.8 parts pyraclostrobin, 0.8 parts metalaxyl, 1.6 parts racemic compound (1), 3 parts calcium lignin sulfonate, lauryl 100 parts of wettable powder is obtained by thoroughly grinding and mixing 2 parts of sodium sulfate and the remainder of the synthetic hydrous silicon oxide.

Formulation Example 218
A wettable powder is obtained by conducting the same operation as in Formulation Example 217 except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 219
The wettable powder is obtained by conducting the same operation as in Formulation Example 217 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 220
The wettable powder is obtained by conducting the same operation as in Formulation Example 218, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 221
Clothianidin 20 parts, boscalid 1.6 parts, pyraclostrobin 0.8 parts, metalaxyl 0.8 parts, tolcrophos methyl 4.0 parts, calcium lignin sulfonate 3 parts sodium lauryl sulfate, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 222
The wettable powder is obtained by conducting the same operation as in Formulation Example 221, except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 223
Clothianidin 20 parts, boscalid 1.6 parts, pyraclostrobin 0.8 parts, metalaxyl 0.8 parts, metconazole 1.6 parts, ethaboxam 0.8 parts, lignin sulfonate calcium 3 parts, lauryl 100 parts of wettable powder is obtained by thoroughly grinding and mixing 2 parts of sodium sulfate and the remainder of the synthetic hydrous silicon oxide.

Formulation Example 224
The wettable powder is obtained by conducting the same operation as in Formulation Example 223, except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 225
Clothianidin 20 parts, boscalid 1.6 parts, pyraclostrobin 0.8 parts, metalaxyl 0.8 parts, racemate of this compound (1) 0.8 parts, ethaboxam 0.8 parts, lignin By thoroughly pulverizing and mixing 3 parts of calcium sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic hydrous silicon oxide, 100 parts of wettable powder is obtained.

Formulation Example 226
A wettable powder is obtained by conducting the same operation as in Formulation Example 225, except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 227
The wettable powder is obtained by conducting the same operation as in Formulation Example 225, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 228
The wettable powder is obtained by conducting the same operation as in Formulation Example 226, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 229
20 parts clothianidin, 1.6 parts boscalid, 0.8 parts pyraclostrobin, 0.8 parts metalaxyl, 4.0 parts tolcrofosmethyl, 0.8 parts ethaboxam, 3 parts calcium lignin sulfonate, By thoroughly pulverizing and mixing 2 parts of sodium lauryl sulfate and the remainder of the synthetic hydrous silicon oxide, 100 parts of a wettable powder is obtained.

Formulation Example 230
The wettable powder is obtained by conducting the same operation as in Formulation Example 229, except that 0.4 part of mefenoxam is used instead of 0.8 part of metalaxyl.

Formulation Example 231
Gently mix 20 parts of clothianidin, 0.8 part of metalaxyl, 8.0 parts of thiuram, 2.4 parts of ipconazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide. This gives 100 parts of wettable powder.

Formulation Example 232
A wettable powder is obtained by performing the same operation as in Formulation Example 231, except that 1.6 parts of trifloxystrobin is used instead of 2.4 parts of ipconazole.

Formulation Example 233
20 parts of clothianidin, 0.4 parts of mefenoxam, 8.0 parts of thiuram, 1.6 parts of trifloxystrobin, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide By grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 234
20 parts of clothianidin, 0.4 parts of mefenoxam, 1.6 parts of trifloxystrobin, 0.8 parts of metconazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide By grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 235
Clothianidin 20 parts, mefenoxam 0.4 parts, trifloxystrobin 1.6 parts, racemate of this compound (1) 0.8 parts, lignin calcium sulfonate 3 parts, sodium lauryl sulfate 2 parts, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 236
The wettable powder is obtained by conducting the same operation as in Formulation Example 235, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 237
20 parts clothianidin, 0.4 parts mefenoxam, 0.8 parts racemic compound (1), 1.6 parts azoxystrobin, 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 238
The wettable powder is obtained by conducting the same operation as in Formulation Example 237 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 239
20 parts of clothianidin, 0.4 parts of mefenoxam, 0.8 parts of racemic compound (1), 4.0 parts of thiabendazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and synthetic hydrous hydroxide By thoroughly grinding and mixing the remaining silicon, 100 parts of a wettable powder is obtained.

Formulation Example 240
The wettable powder is obtained by conducting the same operation as in Formulation Example 239 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 241
20 parts of clothianidin, 0.4 parts of mefenoxam, 4.0 parts of tolcrofosmethyl, 1.6 parts of trifloxystrobin, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide By grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 242
20 parts clothianidin, 0.4 parts mefenoxam, 4.0 parts tolcrofosmethyl, 1.6 parts azoxystrobin, 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide By grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 243
Gently mix 20 parts of clothianidin, 0.4 parts of mefenoxam, 4.0 parts of tolcrofosmethyl, 4.0 parts of thiabendazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide. To obtain 100 parts of wettable powder.

Formulation Example 244
20 parts clothianidin, 0.8 parts metalaxyl, 0.4 parts ethaboxam, 0.8 parts racemic compound (1), 1.6 parts trifloxystrobin, 3 parts calcium lignin sulfonate, By thoroughly pulverizing and mixing 2 parts of sodium lauryl sulfate and the remainder of the synthetic hydrous silicon oxide, 100 parts of a wettable powder is obtained.

Formulation Example 245
The wettable powder is obtained by conducting the same operation as in Formulation Example 244 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 246
20 parts clothianidin, 0.8 parts metalaxyl, 0.4 parts ethaboxam, 0.8 parts racemic compound (1), 1.6 parts azoxystrobin, 3 parts calcium lignin sulfonate, By thoroughly pulverizing and mixing 2 parts of sodium lauryl sulfate and the remainder of the synthetic hydrous silicon oxide, 100 parts of a wettable powder is obtained.

Formulation Example 247
The wettable powder is obtained by conducting the same operation as in Formulation Example 246 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 248
Gently mix 20 parts of clothianidin, 0.4 parts of mefenoxam, 1.6 parts of ipconazole, 4.0 parts of thiuram, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide. To obtain 100 parts wettable powder.

Formulation Example 249
20 parts clothianidin, 0.4 parts mefenoxam, 1.6 parts ipconazole, 0.8 parts racemic compound (1), 3 parts calcium lignin sulfonate, 2 parts sodium lauryl sulfate, and synthetic hydrous hydrate By thoroughly grinding and mixing the remaining silicon, 100 parts of a wettable powder is obtained.

Formulation Example 250
The wettable powder is obtained by conducting the same operation as in Formulation Example 249 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 251
20 parts of clothianidin, 0.4 parts of mefenoxam, 1.6 parts of ipconazole, 4.0 parts of tolcrofos methyl, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of synthetic silicon hydroxide To obtain 100 parts of wettable powder.

Formulation Example 252
20 parts of clothianidin, 0.8 part of the present compound (1), 0.8 part of metconazole, 0.8 part of metalaxyl, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide By grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 253
The wettable powder is obtained by conducting the same operation as in Formulation Example 252, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 254
20 parts of clothianidin, 0.8 part of the present compound (1), 0.8 part of metconazole, 0.8 part of metalaxyl, 0.4 part of ethaboxam, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 255
The wettable powder is obtained by conducting the same operation as in Formulation Example 254 except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 256
20 parts of clothianidin, 0.8 part of the present compound (1), 0.8 part of metconazole, 0.8 part of metalaxyl, 0.4 part of ethaboxam, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and The remaining part of the synthetic hydrous silicon oxide is pulverized and mixed well to obtain 100 parts of a wettable powder.

Formulation Example 257
The wettable powder is obtained by conducting the same operation as in Formulation Example 256, except that the R form of the present compound (1) is used in place of the racemic form of the present compound (1).

Formulation Example 258
Gently mix 20 parts of clothianidin, 0.4 parts of ethaboxam, 1.6 parts of difenoconazole, 1.6 parts of metconazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide. To obtain 100 parts wettable powder.

Formulation Example 259
A flowable formulation is obtained by performing the same operation as in Formulation Example 258, except that 0.2 part of metalaxyl is used in place of ethaboxam.

Formulation Example 260
A flowable formulation is obtained by performing the same operation as in Formulation Example 258 except that 1.6 parts of mefenoxam is used in place of ethaboxam.

Formulation Examples 261 to 266
A flowable formulation is obtained by conducting the same operation as in Formulation Example 258, except that the compound described in [Table 8] and the amount used are used instead of 1.6 parts of metconazole.

Formulation Example 267
20 parts of clothianidin, 0.4 parts of ethaboxam, 1.6 parts of difenoconazole, 0.2 parts of metalaxyl, 1.6 parts of metconazole, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remaining synthetic silicon hydroxide 100 parts of wettable powder is obtained by pulverizing and mixing well.

Formulation Examples 268-273
A flowable formulation is obtained by conducting the same operation as in Formulation Example 267 except that the compound described in [Table 9] and the amount used are used instead of 1.6 parts of metconazole.

Formulation Example 274
20 parts of clothianidin, 0.6 part of ipconazole, 0.8 part of boscalid, 0.4 part of pyraclostrobin, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide are thoroughly mixed. To obtain 100 parts wettable powder

Formulation Example 275
Clothianidin 20 parts, ipconazole 0.6 parts, boscalid 0.8 parts, pyraclostrobin 0.4 parts, metalaxyl 0.2 parts, calcium lignin sulfonate, sodium lauryl sulfate 2 parts, and synthetic hydrous silicon oxide 100 parts of wettable powder is obtained by thoroughly crushing and mixing the remainder.

Formulation Example 276
A flowable formulation is obtained by performing the same operation as in Formulation Example 275, except that 0.16 part of mefenoxam is added instead of metalaxyl.

Formulation Example 277
A flowable formulation is obtained by performing the same operation as in Formulation Example 275, except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 278
Clothianidin 20 parts, ipconazole 0.6 parts, boscalid 0.8 parts, pyraclostrobin 0.4 parts, metalaxyl 0.2 parts, ethaboxam 0.4 parts, lignin calcium sulfonate 3 parts, sodium lauryl sulfate 2 parts And 100 parts of wettable powder are obtained by thoroughly crushing and mixing the remainder of the synthetic hydrous silicon oxide.

Formulation Example 279
By thoroughly mixing 20 parts of clothianidin, 0.6 parts of ipconazole, 8 parts of trifloxystrobin, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide, 100 parts of wettable powder was obtained. obtain.

Formulation Example 280
By thoroughly mixing 20 parts of clothianidin, 0.6 parts of ipconazole, 8 parts of trifloxystrobin, 0.2 parts of metalaxyl, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide 100 parts of wettable powder are obtained.

Formulation Example 281
A flowable formulation is obtained by performing the same operation as in Formulation Example 280, except that 1.6 parts of mefenoxam is added instead of metalaxyl.

Formulation Example 282
A flowable formulation is obtained by performing the same operation as in Formulation Example 280 except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 283
20 parts of clothianidin, 0.6 parts of ipconazole, 8 parts of trifloxystrobin, 0.2 part of metalaxyl, 0.4 part of ethaboxam, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide By thoroughly grinding and mixing, 100 parts of a wettable powder is obtained.

Formulation Example 284
By thoroughly grinding and mixing 20 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the remainder of the synthetic silicon hydroxide, 100% wettable powder. Get a part.

Formulation Example 285
Gently mix 20 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 0.2 part of metalaxyl, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and the rest of the synthetic silicon hydroxide. This gives 100 parts of wettable powder.

Formulation Example 286
A flowable formulation is obtained by performing the same operation as in Formulation Example 285 except that 1.6 parts of mefenoxam is added instead of metalaxyl.

Formulation Example 287
A flowable formulation is obtained by performing the same operation as in Formulation Example 285 except that 0.4 part of ethaboxam is added instead of metalaxyl.

Formulation Example 288
20 parts of clothianidin, 0.6 part of ipconazole, 0.4 part of azoxystrobin, 0.2 part of metalaxyl, 0.4 part of ethaboxam, 3 parts of calcium lignin sulfonate, 2 parts of sodium lauryl sulfate, and synthetic hydrous silicon oxide 100 parts of wettable powder is obtained by thoroughly grinding and mixing the remainder.

Application example 1
The flowable preparation produced in Formulation Example 1 is treated with 500 ml of a dry seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) on 100 kg of dried sorghum seeds to obtain treated seeds. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 2
The flowable preparation produced in Preparation Example 1 is treated with 1000 ml of a seed for 100 kg of dried sorghum seeds using a rotary seed treatment machine (seed dresser, Hans-Ulrich Hege GmbH) to obtain a treated seed. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 3
The flowable formulation produced in Formulation Example 1 is treated with 40 ml of a dry seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) on 10 kg of dried corn seed to obtain a treated seed. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 4
The flowable formulation produced in Formulation Example 1 is treated with 100 ml of a dry seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) on 10 kg of dried corn seed to obtain a treated seed. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 5
The wettable powder produced in Formulation Example 193 is treated with 50 g of dry seeds of corn for 10 kg to obtain treated seeds.
Moreover, it replaces with the wettable powder produced in the formulation example 119, uses each wettable powder produced in the formulation examples 194-288, and performs operation similar to the above, and obtains each process seed.

Application Example 6
The flowable preparation produced in Formulation Example 1 is treated with 50 ml of a seed by using a rotary seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) on 10 kg of dried soybean seeds to obtain treated seeds. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 7
The flowable preparation produced in Formulation Example 1 is treated with 100 ml of a dry seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) on 10 kg of dried soybean seeds to obtain treated seeds. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 8
The flowable preparation produced in Preparation Example 1 is treated with 50 ml of dry seeds using a rotary seed processing machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) to obtain treated seeds. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application example 9
The flowable formulation produced in Formulation Example 1 is treated with 50 ml of spray seeds using a rotary seed treatment machine (seed dresser, manufactured by Hans-Ulrich Hege GmbH) for 10 kg of rapeseed dry seeds to obtain treated seeds. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application Example 10
The flowable formulation produced in Formulation Example 1 is treated with 100 ml of a seed for 10 kg of dried rapeseed using a rotary seed processing machine (seed dresser, Hans-Ulrich Hege GmbH) to obtain a treated seed. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, operation similar to the above is performed, and each process seed is obtained.

Application Example 11
The flowable formulation produced in Formulation Example 1 is treated with 25 ml of a seed seeder (manufactured by Hans-Ulrich Hege GmbH) on 10 kg of potato seed meal to obtain a treated seed meal. .
Moreover, it replaces with the flowable formulation produced in the formulation example 1, and uses each flowable formulation produced in the formulation examples 2-192, and performs operation similar to the above, and obtains each processing seed | species seed | species.

  The following effects of the present invention will be shown by test examples.

Test example 1
The flowable formulation described in Formulation Example 19 is smeared on corn seeds using a rotary seed treatment machine (seed dresser, Hans-Ulrich Hege GmbH) to obtain treated seeds. The treated seeds are allowed to stand overnight, then sown on soil packed in a plastic pot, and covered with soil mixed with Rhizotonia solani separately cultured in a bran medium. Cultivate in a greenhouse while irrigating (hereinafter referred to as a chemical treatment zone). After 10 days of sowing, the number of non-budding seeds is examined, and the disease incidence is calculated by the following “Formula 1”. Using untreated corn seeds, sowing, covering and cultivating are performed in the same manner as in the drug-treated zone (hereinafter referred to as the drug-untreated zone). After 10 days of sowing, the number of non-budding seeds is examined, and the disease incidence is calculated by the following “Formula 1”. By calculating the control value of the drug-treated area by the following “Equation 2” based on the disease severity of the drug-treated area and the non-treated area, it can be confirmed that the drug-treated area exhibits a good pest control effect.

Test example 2
The flowable formulation described in Formulation Example 116 was smeared in a 15 ml centrifuge tube with 1 μl of corn seed, seeded in a 1 / 10000a Wagner pot filled with soil, and allowed to grow in a greenhouse for 12 days. After that, 5 barley beetles are released (hereinafter referred to as test areas). Using the corn seeds that are not treated with the flowable formulation described in Formulation Example 116, seeding, growth, and insect release are performed in the same manner as in the test group (hereinafter referred to as the control group).
In each of the test group and the control group, the number of barley beetle is examined after 7 days of insect release. As a result, since the number of insects in the test group is smaller than the number of insects in the control group, it can be confirmed that the test group shows a good pest control effect.

  According to the present invention, it is possible to provide a pest control composition having high activity and a method capable of effectively controlling pests.

Claims (11)

A pest control composition comprising clothianidin and one or more fungicidal compounds selected from the group (A).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl. A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (B).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (B): A group consisting of a compound represented by the formula (1), pyraclostrobin, azoxystrobin and trifloxystrobin.

A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (C).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (C): A group consisting of metconazole, prothioconazole, triticonazole, tebuconazole, difenoconazole and ipconazole. A pest control composition comprising clothianidin, one or more bactericidal compounds selected from group (A), and one or more bactericidal compounds selected from group (D).
Group (A): A group consisting of mancozeb, mefenoxam and metalaxyl.
Group (D): A group consisting of thiofamate methyl, fludioxonil, tolcrofosmethyl, thiuram, captan, carboxin, boscalid and thiabendazole.   The pest control composition according to any one of claims 1 to 4, wherein the total content of one or more bactericidal compounds selected from the group (A) is 2 to 10000000 parts by weight with respect to 1000 parts by weight of clothianidin. object.   With respect to 1000 parts by weight of clothianidin, the total of one or more bactericidal compounds selected from group (A) is 2 to 10000000 parts by weight, and the total of one or more bactericidal compounds selected from group (B) is: The pest control composition according to claim 2, wherein the content is 2 to 10000000 parts by weight.   With respect to 1000 parts by weight of clothianidin, the total of one or more bactericidal compounds selected from group (A) is 2 to 10000000 parts by weight, and the total of one or more bactericidal compounds selected from group (C) is: The pesticidal composition according to claim 3, wherein the content is 2 to 10000000 parts by weight.   With respect to 1000 parts by weight of clothianidin, the total of one or more bactericidal compounds selected from group (A) is 2 to 10000000 parts by weight, and the total of one or more bactericidal compounds selected from group (D) is: The pesticidal composition according to claim 4, wherein the content is 2 to 10000000 parts by weight.   A pest control method comprising a step of applying an effective amount of the pest control composition according to any one of claims 1 to 8 to a pest or a habitat of the pest.   A method for controlling pests comprising a step of applying an effective amount of the pest control composition according to any one of claims 1 to 8 to plant seeds.   11. The method for controlling pests according to claim 10, wherein the plant seed is a seed of wheat, potato, corn, cotton, soybean, sugar beet, rapeseed, barley or rice.